[1] Green R H.Inhibition of multiplication of influenza virus by extracts of tea[J]. Proceedings of the Society for Experimental Biology and Medicine, 1949, 71(1): 84-85.
[2] Eisfeld A J, Neumann G, Kawaoka Y.At the centre: Influenza A virus ribonucleoproteins[J]. Nature Reviews Microbiology, 2014, 13(1): 28-41.
[3] Paules C I, Sullivan S G, Subbarao K, et al.Chasing seasonal influenza: the need for a universal influenza vaccine[J]. New England Journal of Medicine, 2018, 378(1): 7-9.
[4] Chen G H, Lin Y L, Hsu W L, et al.Significant elevation of antiviral activity of strictinin from Pu'er tea after thermal degradation to ellagic acid and gallic acid[J]. Journal of Food & Drug Analysis, 2015, 23(1): 116-123.
[5] Xu J, Xu Z, Zheng W.A review of the antiviral role of green tea catechins[J]. Molecules, 2017, 22(8): 1337. doi: 10.3390/molecules22081337.
[6] 黄深惠, 汤有志, 周雪梦, 等. 茶多酚体内外抗流感病毒作用研究[J]. 茶叶科学, 2010, 30(4): 302-308.
Huang S H, Tang Y Z, Zhou M X, et al.Study on anti-influenza virus effect of tea polyphenols in vitro and in vivo[J]. Journal of Tea Science, 2010, 30(4): 302-308.
[7] 彭慧琴, 蔡卫民, 项哨. 茶多酚体外抗流感病毒A3的作用[J]. 茶叶科学, 2003, 23(1): 79-81.
Peng H Q, Cai W M, Xiang S.In vitro anti-influenza virus effect of tea polyphenols[J]. Journal of Tea Science, 2003, 23(1): 79-81.
[8] Zu M, Yang F, Zhou W, et al.In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives[J]. Antiviral Research, 2012, 94(3): 217-224.
[9] 肖潇, 杨占秋, 石丽桥, 等. 表没食子儿茶素没食子酸酯抗流感病毒作用的研究[J]. 中国中药杂志, 2008, 33(22): 2678-2682.
Xiao X, Yang Z Q, Shi L Q, et al.Antiviral effect of epigallocatechin gallate (EGCG) on influenza A virus[J]. China Journal of Chinese Materia Medica, 2008, 33(22): 2678-2682.
[10] 谭文界, 石丽桥, 祝汪洋, 等. (-)表没食子儿茶素-3-O-没食子酸酯(EGCG)的抗流感病毒实验[J]. 中国医院药学杂志, 2009, 29(5): 376-378.
Tan W J, Shi L Q, Zhu W Y, et al.Study on the effect of anti-influenza virus of EGCG[J]. Chinese Journal of Hospital Pharmacy, 2009, 29(5): 376-378.
[11] 谢慧珺, 刘妮, 丁伟, 等. 茶多酚主要成分EGCG体外抗流感病毒FM1株作用[J]. 广州中医药大学学报, 2012, 29(2): 172-175, 224.
Xie H J, Liu N, Ding W, et al.Antiviral effect of tea catechin EGCG on influenza virus FM1 strain in vitro[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2012, 29(2): 172-175, 224.
[12] Yang Z F, Bai L P, Huang W B, et al.Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure-activity relationship analysis[J]. Fitoterapia, 2014, 93: 47-53.
[13] Noda M, Toda M, Endo W, et al.The anti-influenza virus activities of catechins[J]. Jpn J Bacteriol, 1994, 49: 117.
[14] Song J M, Lee K H, Seong B L.Antiviral effect of catechins in green tea on influenza virus[J]. Antiviral Research, 2005, 68(2): 66-74.
[15] Nakayama M, Suzuki K, Toda M, et al.Inhibition of the infectivity of influenza virus by tea polyphenols[J]. Antiviral Research, 1993, 21(4): 289-299.
[16] 李湘潋, 刘叔文, 杨洁. 茶黄素衍生物抗甲型流感病毒的作用研究[J]. 中草药, 2013, 44(17): 2437-2441.
Li X L, Liu S W, Yang J.Effect of theaflavin derivatives on influenza A virus[J]. Chinese Traditional and Herbal Drugs, 2013, 44(17): 2437-2441.
[17] Imanishi N, Tuji Y, Katada Y, et al.Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells[J]. Microbiology & Immunology, 2002, 46(7): 491-494.
[18] Furuta T, Hirooka Y, Abe A, et al.Concise synthesis of dideoxy-epigallocatechin gallate (DO-EGCG) and evaluation of its anti-influenza virus activity[J]. Cheminform, 2007, 38(40): 3095-3098.
[19] Ling J X, Wei F, Li N, et al.Amelioration of influenza virus-induced reactive oxygen species formation by epigallocatechin gallate derived from green tea[J]. Acta Pharmacologica Sinica, 2012, 33(12): 1533-1541.
[20] Oxford J S, Lambkin R, Guralnik M, et al.Preclinical in vitro activity of QR-435 against influenza A virus as a virucide and in paper masks for prevention of viral transmission[J]. American Journal of Therapeutics, 2007, 14(5): 455-461.
[21] Sriwilaijaroen N, Fukumoto S, Kumagai K, et al.Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1N1 viruses: Its role in viral hemagglutination and neuraminidase inhibition[J]. Antiviral Research, 2012, 94(2): 139-146.
[22] Oxford J S, Lambkin R, Guralnik M, et al.In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection[J]. American Journal of Therapeutics, 2007, 14(5): 462-468.
[23] Lee H J, Lee Y N, Youn H N, et al.Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens[J]. Poultry Science, 2011, 91(1): 66-73.
[24] Leung P C.Antibacterial and antiviral effects of tea-from influenza to SARS[J]. Protective Effects of Tea on Human Health, 2006(16): 158-171.
[25] Park M, Yamada H, Matsushita K, et al.Green tea consumption is inversely associated with the incidence of influenza infection among schoolchildren in a tea plantation area of Japan[J]. Journal of Nutrition, 2011, 141(10): 1862-1870.
[26] Rowe C, Nantz M, Bukowski J, et al.Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gamma, delta t cell function: A randomized, double-blind, placebo-controlled study[J]. Journal of the American College of Nutrition, 2007, 26(5): 445-452.
[27] Matsumoto K, Yamada H, Takuma N, et al.Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial[J]. BMC Complementary and Alternative Medicine, 2011, 11: 15. doi: 10.1186/1472-6882-11-15.
[28] Iwata M, Toda M, Nakayama M, et al.Prophylactic effect of black tea extract as gargle against influenza[J]. Kansenshōgaku Zasshi the Journal of the Japanese Association for Infectious Diseases, 1997, 71(6): 487-494.
[29] Noda T, Ojima T, Hayasaka S, et al.Gargling for oral hygiene and the development of fever in childhood: a population study in Japan[J]. Journal of Epidemiology, 2012, 22(1): 45-49.
[30] Yamada H, Takuma N, Daimon T, et al.Gargling with tea catechin extracts for the prevention of influenza infection in elderly nursing home residents: a prospective clinical study[J]. Journal of Alternative and Complementary Medicine, 2006, 12(7): 669-672.
[31] Ide K, Yamada H, Kawasaki Y.Effect of gargling with tea and ingredients of tea on the prevention of influenza infection: A meta-analysis[J]. BMC Public Health, 2016, 16: 396. doi: 10.1186/s12889-016-3083-0.
[32] Ide K, Yamada H, Matsushita K, et al.Effects of green tea gargling on the prevention of influenza infection in high school students: a randomized controlled study[J]. Plos One, 2014, 9: e96373. doi: 10.1371/journal.pone.0096373.
[33] Steinmann, Buer, Pietschmann, et al. Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea[J]. British Journal of Pharmacology, 2013, 168: 1059-1073.
[34] Zhu N, Zhang D, Wang W, et al.A novel coronavirus from patients with pneumonia in China, 2019[J]. New England Journal of Medicine, 2020, 382: 727-733.
[35] Cui J, Li F, Shi Z L.Origin and evolution of pathogenic coronaviruses[J]. Nature Reviews Microbiology, 2019, 17: 181-192.
[36] Jiang Y, Xu J, Zhou C, et al.Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome[J]. American Journal of Respiratory and Critical Care Medicine, 2005, 171(8): 850-857.
[37] Peihua N, Guangyu Z, Yao D.A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice[J]. Science China, 2018, 61(10): 148-150.
[38] Wu C R, Zheng M Z, Yang Y, et al.Furin, a potential therapeutic target for COVID-19[J]. iScience, 2020, 23(10): 101642. doi: 10.1016/j.isci.2020.101642.
[39] Chen C N, Lin C P C, Huang K K, et al. Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3'-digallate (TF3)[J]. Evidence-Based Complementary and Alternative Medicine, 2005, 2(2): 209-215.
[40] Kamath A B, Wang L, Das H, et al.Antigens in tea-beverage prime human Vγ2Vδ2 T cells in vitro and in vivo for memory and nonmemory antibacterial cytokine responses[J]. PNAS, 2003, 100(10): 6009-6014.
[41] Matsumoto M, Mukai T, Furukawa S, et al.Inhibitory effects of epigallocatechin gallate on the propagation of bovine coronavirus in Madin-Darby bovine kidney cells[J]. Animal Science Journal, 2005, 76: 507-512.
[42] Clark K J, Grant P G, Sarr A B, et al.An in vitro study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections[J]. Veterinary Microbiology, 1998, 63(2/4): 147-157.
[43] Liang W L, He L, Ning P B, et al.(+)-Catechin inhibition of transmissible gastroenteritis coronavirus in swine testicular cells is involved its antioxidation[J]. Research in Veterinary Science, 2015, 103: 28-33.
[44] Deeks S G, Overbaugh J, Phillips A, et al.HIV infection[J]. Nature Reviews Disease Primers, 2015, 1: 15035. doi: 10.1038/nldp.2015.35.
[45] Fauci A S, Redfield R R, Sigounas G, et al.Ending the HIV epidemic: a plan for the United States[J]. The Journal of the American Medical Association, 2019, 321: 844-845.
[46] Huang N, Yang L M, Li X L et al. Anti-HIV activities of extracts from Pu-erh tea[J]. Chinese Journal of Natural Medicines, 2012, 10(5): 347-352.
[47] Pasetto S, Pardi V, Murata R M.Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model[J]. Plos One, 2014, 9(12): e115323. doi: 10.1371/journal.pone.0115323.
[48] Su Y L, Rhim J Y, Park W B.Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro[J]. Archives of Pharmacal Research, 2005, 28(11): 1293-1301.
[49] Nakane H, Ono K.Differential inhibition of HIV-reverse transcriptase and various DNA and RNA polymerases by some catechin derivatives[J]. Nucleic Acids Symp Ser, 1989, 21(21): 115-116.
[50] Chang C, Hsu F, Lin J.Inhibitory effects of polyphenolic catechins from Chinese green tea on HIV reverse transcriptase activity[J]. Journal of Biomedical Science, 1994, 1(3): 163-166.
[51] Li S, Hattori T, Kodama E N.Epigallocatechin gallate inhibits the HIV reverse transcription step[J]. Antiviral Chemistry and Chemotherapy, 2011, 21(6): 239-243.
[52] Fassina G, Buffa A, Benelli R, et al.Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent[J]. Aids, 2002, 16(6): 939-941.
[53] Yamaguchi K, Honda M, Ikigai H, et al.Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1)[J]. Antiviral Research, 2002, 53(1): 19-34.
[54] Freed E O.HIV-1 assembly, release and maturation[J]. Nature Reviews Microbiology, 2015, 13(8): 484-496.
[55] Hamza A, Zhan C G.How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors[J]. Journal of Physical Chemistry B, 2006, 110(6): 2910-2917.
[56] Kawai K, Tsuno N H, Kitayama J, et al.Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding[J]. Journal of Allergy & Clinical Immunology, 2003, 112(5): 951-957.
[57] Williamson M, Mccormick T, Nance C, et al.Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy[J]. Journal of Allergy & Clinical Immunology, 2006, 118(6): 1369-1374.
[58] Nance C L, Siwak E B, Shearer W T.Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy[J]. Journal of Allergy & Clinical Immunology, 2009, 123(2): 459-465.
[59] Jiang F, Chen W, Yi K, et al.The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors[J]. Clinical Immunology, 2010, 137(3): 347-356.
[60] Liu S, Lu H, Zhao Q, et al.Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41[J]. Biochimica et Biophysica Acta General Subjects, 2005, 1723(1/3): 270-281.
[61] Yang J, Li L, Tan S, et al.A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection[J]. Fitoterapia, 2012, 83(2): 348-355.
[62] Liu S W, Wu S G, Jiang S B.HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds[J]. Current Pharmaceutical Design, 2007, 13(2): 143-162.
[63] Ehrnhoefer D E, Bieschke J, Boeddrich A, et al.EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers[J]. Nature Structural & Molecular Biology, 2008, 15(6): 558-566.
[64] Hauber I, Hohenberg H, Holstermann B, et al.The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection[J]. PNAS, 2009, 106(22): 9033-9038.
[65] Hartjen P, Frerk S, Hauber I, et al.Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG[J]. Aids Research & Therapy, 2012, 9: 2. doi: 10.1186/1742-6405-9-2.
[66] Popovych N, Brender J R, Soong R, et al.Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286)[J]. Journal of Physical Chemistry B, 2012, 116(11): 3650-3658.
[67] Yang J, Li L, Jin H, et al.Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission[J]. AIDS Research and Human Retroviruses, 2012, 28(11): 1498-1508.
[68] Manns M P, Buti M, Gane E, et al.Hepatitis C virus infection[J]. Nature reviews Disease primers, 2017, 3: 17006. doi: 10.1038/nrdp.2017.6.
[69] Yuen M F, Chen D S, Dusheiko G M, et al.Hepatitis B virus infection[J]. Nature Reviews Disease Primers, 2018, 338(18): 1312-1313.
[70] Razavi-Shearer D, Gamkrelidze I, Nguyen M H, et al.Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study[J]. Lancet Gastroenterol Hepatol, 2018, 3(6): 383-403.
[71] Xu J, Wang J, Deng F, et al.Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro[J]. Antiviral Research, 2008, 78(3): 242-249.
[72] Pei S, Zhang Y, Xu H, et al.Inhibition of the replication of hepatitis B virus in vitro by Pu-erh tea extracts[J]. Journal of Agricultural & Food Chemistry, 2011, 59(18): 9927-9934.
[73] 廖银武. 白茶提取物抗乙型肝炎病毒的研究[D]. 福州: 福建农林大学, 2010.
Liao Y W.The study of anti-HBV effect of white tea extract [D]. Fuzhou: Fujian Agriculture and Forestry University, 2010.
[74] Ye P, Zhang S, Zhao L, et al.Tea polyphenols exerts anti-hepatitis B virus effects in a stably HBV-transfected cell line[J]. Journal of Huazhong University of Science and Technology (Medical Sciences), 2009, 29(2): 169-172.
[75] Xu J, Gu W, Li C, et al.Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha[J]. Journal of Natural Medicines, 2016, 70(3): 584-591.
[76] Pang J Y, Zhao K J, Wang J B, et al.Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro[J]. Journal of Zhejiang University-Science B, 2014, 15(6): 533-539.
[77] Karamese M, Aydogdu S, Karamese S A, et al.Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication[J]. Asian Pacifc Journal of Cancer Prevention, 2015, 16(10): 4199-4202.
[78] Cheng Z K, Sun G, Guo W, et al.Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines[J]. Virologica Sinica, 2015, 30: 261-268.
[79] Zheng Z, Li J, Sun J, et al.Inhibition of HBV replication by theophylline[J]. Antiviral Research, 2011, 89(2): 149-155.
[80] He W, Lx LX, Liao QJ, et al.Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication-inducible cell line[J]. World Journal of Gastroenterology, 2011, 17(11): 1507-1514.
[81] Yan H, Zhong G C, Xu G W, et al.Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus[J]. Elife Sciences, 2012, 1: e00049. doi: 10.7554/eLife.00049.
[82] Yan H, Peng B, He W, et al.Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide[J]. Journal of Virology, 2013, 87(14): 7977-7991.
[83] Huang H C, Tao M H, Hung T M, et al.(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes[J]. Antiviral Research, 2014, 111: 100-111.
[84] Zhong L, Hu J, Shu W, et al.Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication[J]. Cell Death & Disease, 2015, 6(5): e1770. doi: 10.1038/cddis.2015.136.
[85] Lai Y H, Sun C P, Huang H C, et al.Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice[J]. BMC Complementary and Alternative Medicine, 2018, 18: 248. doi: 10.1186/s12906-018-2316-4.
[86] Wang Z Y, Li Y Q, Guo Z W, et al.ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication[J]. Acta Pharmacologica Sinica, 2020, 41(2): 278-285.
[87] Thrift A P, El-Serag H B, Kanwal F. Global epidemiology and burden of HCV infection and HCV-related disease[J]. Nat Rev Gastroenterol Hepatol, 2016, 14(2): 122-132.
[88] Calland N, Albecka A, Belouzard S, et al.(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry[J]. Hepatology, 2012, 55(3): 720-729.
[89] Ciesek S, Hahn T V, Che C C, et al.The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry[J]. Hepatology, 2011, 54(6): 1947-1955.
[90] Chen C, Qiu H, Gong J, et al.(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus[J]. Archives of Virology, 2012, 157(7): 1301-1312.
[91] Zuo G, Li Z, Chen L, et al.Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) maxim against HCV NS3 serine protease[J]. Antiviral Research, 2007, 76(1): 86-92.
[92] Fukazawa H, Suzuki T, Wakita T, et al.A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus[J]. Biological & Pharmaceutical Bulletin, 2012, 35(8): 1320-1327.
[93] Mekky R Y, El-Ekiaby N, Sobky S A E, et al. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models[J]. Archives of Virology, 2019, 164(6): 1587-1595.
[94] Witteveldt J, Evans M J, Bitzegeio J, et al.CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells[J]. The Journal of General Virology, 2009, 90(1): 48-58.
[95] Calland N, Sahuc M E, Belouzard S, et al.Polyphenols inhibit hepatitis C virus entry by a new mechanism of action[J]. Journal of Virology, 2015, 89: 10053-10063.
[96] Lin Y T, Wu Y H, Chin-Kai T, et al.Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation[J]. Plos One, 2013, 8(1): e54466. doi: 10.1371/journal.pone.0054466.
[97] Chowdhury P, Sahuc Me, Rouillé Y, et al.Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture[J]. Plos One, 2018, 13(11): e0198226. doi: 10.1371/journal.pone.0198226.
[98] Crosbie E J, Einstein D H, Franceschi S, et al.Human papillomavirus and cervical cancer[J]. The Lancet, 2013, 382: 889-899.
[99] Zou C, Liu H, Feugang J M, et al.Green tea compound in chemoprevention of cervical cancer[J]. International Journal of Gynecologic Cancer, 2010, 20(4): 617-624.
[100] Qiao Y, Cao J, Xie L, et al.Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells[J]. Archives of Pharmacal Research, 2009, 32(9): 1309-1315.
[101] Yokoyama M, Noguchi M, Nakao Y, et al.The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines[J]. Gynecologic Oncology, 2004, 92(1): 197-204.
[102] He L, Zhang E, Shi J, et al.(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α[J]. Cancer Chemotherapy & Pharmacology, 2013, 71(3): 713-725.
[103] Singh M, Tyagi S, Bhui K, et al.Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols[J]. Investigational New Drugs, 2010, 28(3): 216-224.
[104] Singh M, Singh R, Bhui K, et al.Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-κB and Akt activation in human cervical cancer cells[J]. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 2011, 19: 245-257.
[105] Ahn W S, Yoo J, Huh S W, et al.Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions[J]. European Journal of Cancer Prevention, 2003, 12(5): 383-390.
[106] Tatti S, Stockfleth E, Beutner K R, et al.Polyphenon E: a new treatment for external anogenital warts[J]. British Journal of Pharmacology, 2010, 162(1): 176-184.
[107] Stockfleth E, Meyer T.The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts[J]. Expert Opinion on Biological Therapy, 2012, 12(6): 783-793.
[108] Garcia F A, Cornelison T, Nuño T, et al.Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia[J]. Gynecologic Oncology, 2013, 132: 377-382.
[109] Date A A, Destache C J.Natural polyphenols: potential in the prevention of sexually transmitted viral infections[J]. Drug Discovery Today, 2016, 21(2): 333-341.
[110] Johnson D C, Baines J D.Herpesviruses remodel host membranes for virus egress[J]. Nature Reviews Microbiology, 2011, 9(5): 382-394.
[111] Molloy S.Back to the HSV drawing board[J]. Nature Reviews Microbiology, 2012, 10: 82. doi: 10.1038/nrmicro2744.
[112] Savi L A, Barardi C R, Simões C M.Evaluation of antiherpetic activity and genotoxic effects of tea catechin derivatives[J]. Journal of Agricultural & Food Chemistry, 2006, 54(7): 2552-2557.
[113] Isaacs C E, Wen G Y, Xu W, et al.Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus[J]. Antimicrobial Agents & Chemotherapy, 2008, 52(3): 962-970.
[114] Colpitts C C, Schang L M.A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans[J]. Journal of Virology, 2014, 88(14): 7806-7817.
[115] Daikoku T, Horiba K, Miyata K, et al.Polyphenols including catechin from green tea with in vitro antiviral activity exhibited anti-herpes simplex virus activity but not anti-influenza virus activity in mice[J]. Journal of Traditional Medicines, 2011, 28(2): 63-72.
[116] Isaacs C E, Xu W, Merz G, et al.Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus[J]. Antimicrobial Agents & Chemotherapy, 2011, 55(12): 5646-5653.
[117] Chang L K, Wei T T, Chiu Y F, et al.Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate[J]. Biochemical & Biophysical Research Communications, 2003, 301(4): 1062-1068.
[118] Yan Z, Hai W, Zhao X R, et al.Epigallocatechin-3-gallate interferes with EBV-encoding AP-1 signal transduction pathway[J]. Zhonghua Zhong Liu Za Zhi, 2004, 26(7): 393-397.
[119] Liu S, Li H, Chen L, et al.(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells[J]. Carcinogenesis, 2012, 34(3): 627-637.
[120] Chen Y L, Tsai H L, Peng C W.EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1[J]. Biochemical and Biophysical Research Communications, 2012, 417(3): 1092-1099.
[121] 张国营, 何丽娜. 红茶,青茶,黑茶抗人轮状病毒的实验研究[J]. 中国病毒学, 1993, 8(2): 151-153.
Zhang G Y, He L N.An experimental study on antiviral activities of black tea, blue tea and dark tea against rotavirus[J]. Virologica Sinica, 1993, 8(2): 151-153.
[122] Ho H Y, Cheng M L, Weng S F, et al.Antiviral effect of epigallocatechin gallate on enterovirus 71[J]. Journal of Agricultural and Food Chemistry, 2009, 57(14): 6140-6147.
[123] Weber J M, Ruzindana-Umunyana A, Imbeault L, et al.Inhibition of adenovirus infection and adenain by green tea catechins[J]. Antiviral Research, 2003, 58(2): 167-173.
[124] Weber C, Sliva K, Von Rhein C, et al.The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection[J]. Antiviral Research, 2015, 113: 1-3.
[125] Carneiro B M, Batista M N, Braga A C S, et al. The green tea molecule EGCG inhibits Zika virus entry[J]. Virology, 2016, 496: 215-218.
[126] Bansal S, Choudhary S, Sharma M, et al.Tea: a native source of antimicrobial agents[J]. Food Research International, 2013, 53(2): 568-584.
[127] Evers D L, Chao C F, Wang X, et al.Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action[J]. Antiviral Research, 2005, 68(3): 124-134.
[128] NAIR M P N, Kandaswami C, Mahajan S, et al. The flavonoid, quercetin, differentially regulates Th-1 (IFNγ) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells[J]. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 2002, 1593(1): 29-36.
[129] Chow H H, Cai Y, Hakim I A, et al.Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals[J]. Clinical Cancer Research, 2003, 9(9): 3312-3319.
[130] Mori S, Miyake S, Kobe T, et al.Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length[J]. Bioorganic & Medicinal Chemistry Letters, 2008, 18(14): 4249-4252.
[131] De Oliveira A, Adams S D, Lee L H, et al.Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate[J]. Food & Chemical Toxicology, 2013, 52: 207-215.
[132] Kaihatsu K, Mori S, Matsumura H, et al.Broad and potent anti-influenza virus spectrum of epigallocatechin-3-O-gallate-monopalmitate[J]. Journal of Molecular & Genetic Medicine, 2009, 3(2): 195-197.
[1] Zhong Y, Ma C M, Shahidi F.Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives[J]. Journal of Functional Foods, 2012, 4(1): 87-93.